SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-23-003630
Filing Date
2023-05-30
Accepted
2023-05-30 07:00:08
Documents
8
Period of Report
2023-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_052623.htm 6-K 7774
2 EXHIBIT 99.1 exh_991.htm EX-99.1 6902
3 EXHIBIT 99.2 exh_992.htm EX-99.2 489291
4 EXHIBIT 99.3 exh_993.htm EX-99.3 972
5 GRAPHIC logo.jpg GRAPHIC 5635
6 GRAPHIC perf.jpg GRAPHIC 43530
7 GRAPHIC card_1.jpg GRAPHIC 279845
8 GRAPHIC card_2.jpg GRAPHIC 553534
  Complete submission text file 0001171843-23-003630.txt   1721063
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40858 | Film No.: 23971354
SIC: 2834 Pharmaceutical Preparations